Design and synthesis of 2-N-substituted indazolone derivatives as non-carboxylic acid glycogen synthase activators.

Bioorg Med Chem Lett

Discovery Chemistry, Small Molecule Research, Pharmaceutical Research and Early Drug Development, Hoffmann-La Roche Inc., 340 Kingsland Street, Nutley, NJ 07110, United States.

Published: May 2013

Glycogen synthase (GS) catalyzes the transfer of glucose residues from UDP-glucose to a glycogen polymer chain, a critical step for glucose storage. Patients with type 2 diabetes normally exhibit low glycogen levels and decreased muscle glucose uptake is the major defect in whole body glucose disposal. Therefore, activating GS may provide a potential approach for the treatment of type 2 diabetes. In order to identify non-carboxylic acids GS activators, we designed and synthesized a series of 2-N-alkyl- and 2-N-aryl-indazolone derivatives and studied their activity in activating human GS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2013.03.049DOI Listing

Publication Analysis

Top Keywords

glycogen synthase
8
type diabetes
8
design synthesis
4
synthesis 2-n-substituted
4
2-n-substituted indazolone
4
indazolone derivatives
4
derivatives non-carboxylic
4
non-carboxylic acid
4
glycogen
4
acid glycogen
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!